临床误诊误治
臨床誤診誤治
림상오진오치
CLINICAL MISDIAGNOSIS & MISTHERAPY
2014年
7期
16-18
,共3页
程慧%王生池%臧会玲%范卫泽%王立忠%刘红娟%沈晓辉%梁少卿
程慧%王生池%臧會玲%範衛澤%王立忠%劉紅娟%瀋曉輝%樑少卿
정혜%왕생지%장회령%범위택%왕립충%류홍연%침효휘%량소경
脓毒症%氮末端B型脑钠肽前体%APACHEⅡ评分%预后
膿毒癥%氮末耑B型腦鈉肽前體%APACHEⅡ評分%預後
농독증%담말단B형뇌납태전체%APACHEⅡ평분%예후
Sepsis%NT-proBNP%APACHE II score%Prognosis
目的:评价 N 端 B 型脑钠肽前体(NT-proBNP)对脓毒症患者预后评估的临床价值。方法选取2011年1月—2013年6月我院重症医学科收治的60例脓毒症,按患者入院28 d 后的生存情况分为生存组42例和死亡组18例,比较两组入院2 h 内 NT-proBNP 水平及入院24 h 内急性生理学与慢性健康状态评价系统Ⅱ(acute physiology and chronichealth evaluation, APACHE Ⅱ)评分,通过建立受试者工作特征(ROC)曲线探讨 NT-proBNP 对脓毒症患者预后评估的价值。结果入院2 h 内,死亡组 NT-proBNP 水平为(5873.24±1768.37) pg/ ml 明显高于生存组的(2170.45±625.28)pg/ ml,差异有统计学意义(t =2.660,P =0.015);死亡组 APACHE Ⅱ评分为(26.47±5.32)分,也明显高于生存组的(21.54±4.35)分,差异有统计学意义(t =2.390,P =0.020)。 Pearson 相关性分析显示,NT-proBNP与 APACHE Ⅱ评分呈正相关(r =0.509,P =0.003)。 NT-proBNP 水平和 APACHE Ⅱ评分的 ROC 曲线下面积分别为0.730和0.715,两者评估预后效能相仿。结论 NT-proBNP 对脓毒症患者预后评估有较好的临床价值,可作为脓毒症患者预后判断的一个参考指标。
目的:評價 N 耑 B 型腦鈉肽前體(NT-proBNP)對膿毒癥患者預後評估的臨床價值。方法選取2011年1月—2013年6月我院重癥醫學科收治的60例膿毒癥,按患者入院28 d 後的生存情況分為生存組42例和死亡組18例,比較兩組入院2 h 內 NT-proBNP 水平及入院24 h 內急性生理學與慢性健康狀態評價繫統Ⅱ(acute physiology and chronichealth evaluation, APACHE Ⅱ)評分,通過建立受試者工作特徵(ROC)麯線探討 NT-proBNP 對膿毒癥患者預後評估的價值。結果入院2 h 內,死亡組 NT-proBNP 水平為(5873.24±1768.37) pg/ ml 明顯高于生存組的(2170.45±625.28)pg/ ml,差異有統計學意義(t =2.660,P =0.015);死亡組 APACHE Ⅱ評分為(26.47±5.32)分,也明顯高于生存組的(21.54±4.35)分,差異有統計學意義(t =2.390,P =0.020)。 Pearson 相關性分析顯示,NT-proBNP與 APACHE Ⅱ評分呈正相關(r =0.509,P =0.003)。 NT-proBNP 水平和 APACHE Ⅱ評分的 ROC 麯線下麵積分彆為0.730和0.715,兩者評估預後效能相倣。結論 NT-proBNP 對膿毒癥患者預後評估有較好的臨床價值,可作為膿毒癥患者預後判斷的一箇參攷指標。
목적:평개 N 단 B 형뇌납태전체(NT-proBNP)대농독증환자예후평고적림상개치。방법선취2011년1월—2013년6월아원중증의학과수치적60례농독증,안환자입원28 d 후적생존정황분위생존조42례화사망조18례,비교량조입원2 h 내 NT-proBNP 수평급입원24 h 내급성생이학여만성건강상태평개계통Ⅱ(acute physiology and chronichealth evaluation, APACHE Ⅱ)평분,통과건립수시자공작특정(ROC)곡선탐토 NT-proBNP 대농독증환자예후평고적개치。결과입원2 h 내,사망조 NT-proBNP 수평위(5873.24±1768.37) pg/ ml 명현고우생존조적(2170.45±625.28)pg/ ml,차이유통계학의의(t =2.660,P =0.015);사망조 APACHE Ⅱ평분위(26.47±5.32)분,야명현고우생존조적(21.54±4.35)분,차이유통계학의의(t =2.390,P =0.020)。 Pearson 상관성분석현시,NT-proBNP여 APACHE Ⅱ평분정정상관(r =0.509,P =0.003)。 NT-proBNP 수평화 APACHE Ⅱ평분적 ROC 곡선하면적분별위0.730화0.715,량자평고예후효능상방。결론 NT-proBNP 대농독증환자예후평고유교호적림상개치,가작위농독증환자예후판단적일개삼고지표。
Objective To evaluate the prognosis value of immunoreactive amino-terminal pro-brain natriuretic peptide (NT-proBNP) on patients with sepsis. Methods A total of 60 sepsis patients admitted during January 2011 and June 2013 were divided into survival group (n = 42) and death group (n = 18) based on the survival status on the 28th d after admission. Serum NT-proBNP levels within 2 h after admission and APACHE II (acute physiology and chronic health evaluation II) scores within 24 h after admission in the two groups were compared, and the value of NT-proBNP on prognostic assessment of sepsis patients were investigated by establishment of the ROC curve of work characteristics. Results The serum level of NT-proBNP in death group (5873. 24 ± 1768. 37)pg/ ml was significant higher than (2170. 45 ± 625. 28) pg/ ml in the survival group, and the difference was statistically significant (t = 2. 660, P = 0. 015); APECHE II score of (26. 47 ± 5. 32) in death group was significantly higher than (21. 54 ± 4. 35)in survival group, and the difference was also statistically significant (t =2. 390, P = 0. 020). Pearson correlation analysis indicated that the serum NT-proBNP level had a positive correlation with APACHE II score (r = 0. 509, P = 0. 003). The area under the ROC curve for NT-proBNP level and APACHE II score were 0. 730 and 0. 715 respectively, which had a similar prognosis assessment value in sepsis patients. Conclusion NT-proBNP has a better clinical value on the prognosis assessment of sepsis patients, and can be served as a reference index for the prog-nosis evaluation in sepsis patients.